Follow
Peter E. Penson
Peter E. Penson
Professor of Pharmacy Practice; LJMU; Liverpool Centre for Cardiovascular Science Twitter @DrPenson
Verified email at ljmu.ac.uk - Homepage
Title
Cited by
Cited by
Year
Prevalence of statin intolerance: a meta-analysis
I Bytyçi, PE Penson, DP Mikhailidis, ND Wong, AV Hernandez, ...
European heart journal 43 (34), 3213-3223, 2022
2142022
The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis
B Sosnowska, M Mazidi, P Penson, A Gluba-Brzózka, J Rysz, M Banach
Atherosclerosis 265, 275-282, 2017
1742017
Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis
T Gjuladin-Hellon, IG Davies, P Penson, R Amiri Baghbadorani
Nutrition reviews 77 (3), 161-180, 2019
1262019
The role of nutraceuticals in the prevention of cardiovascular disease
B Sosnowska, P Penson, M Banach
Cardiovascular diagnosis and therapy 7 (Suppl 1), S21, 2017
1102017
Introducing the ‘Drucebo’effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label …
PE Penson, GBJ Mancini, PP Toth, SS Martin, GF Watts, A Sahebkar, ...
Journal of Cachexia, Sarcopenia and Muscle 9 (6), 1023-1033, 2018
107*2018
Inclisiran—new hope in the management of lipid disorders?
K Dyrbuś, M Gąsior, P Penson, KK Ray, M Banach
Journal of clinical lipidology 14 (1), 16-27, 2020
1032020
LDL-C: lower is better for longer—even at low risk
PE Penson, M Pirro, M Banach
BMC medicine 18, 1-6, 2020
1002020
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)
F Zhubi-Bakija, G Bajraktari, I Bytyçi, DP Mikhailidis, MY Henein, ...
Clinical nutrition 40 (1), 255-276, 2021
912021
The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis
SM Maierean, MC Serban, A Sahebkar, S Ursoniu, A Serban, P Penson, ...
Journal of clinical lipidology 11 (6), 1393-1406, 2017
88*2017
Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials
M Dinca, MC Serban, A Sahebkar, DP Mikhailidis, PP Toth, SS Martin, ...
Pharmacol Res 107, 360-71, 2016
88*2016
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical …
PE Penson, DL Long, G Howard, PP Toth, P Muntner, VJ Howard, ...
European Heart Journal 39 (40), 3641-3653, 2018
872018
Statin-induced nitric oxide signaling: mechanisms and therapeutic implications
AM Gorabi, N Kiaie, S Hajighasemi, M Banach, PE Penson, ...
Journal of clinical medicine 8 (12), 2051, 2019
862019
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
M Banach, PE Penson, Z Fras, M Vrablik, D Pella, Ž Reiner, SM Nabavi, ...
Pharmacological research 158, 104891, 2020
84*2020
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
M Banach, PE Penson, M Vrablik, M Bunc, K Dyrbus, J Fedacko, D Gaita, ...
Pharmacological research 166, 105499, 2021
80*2021
Intake of caffeine and its association with physical and mental health status among university students in Bahrain
H Jahrami, M Al-Mutarid, PE Penson, M Al-Islam Faris, Z Saif, L Hammad
Foods 9 (4), 473, 2020
672020
Association of types of dietary fats and all-cause and cause-specific mortality: a prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants
M Mazidi, DP Mikhailidis, N Sattar, PP Toth, S Judd, MJ Blaha, ...
Clinical nutrition 39 (12), 3677-3686, 2020
602020
What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?
M Banach, PE Penson
Cardiovascular Research 115 (3), e26-e31, 2019
592019
Evidence-based assessment of lipoprotein (a) as a risk biomarker for cardiovascular diseases–some answers and still many questions
K Kotani, MC Serban, P Penson, G Lippi, M Banach
Critical reviews in clinical laboratory sciences 53 (6), 370-378, 2016
542016
What do we know about the role of lipoprotein (a) in atherogenesis 57 years after its discovery?
B Cybulska, L Kłosiewicz-Latoszek, PE Penson, M Banach
Progress in cardiovascular diseases 63 (3), 219-227, 2020
522020
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials
D Brie, A Sahebkar, PE Penson, M Dinca, S Ursoniu, MC Serban, ...
Journal of hypertension 34 (12), 2318-2329, 2016
522016
The system can't perform the operation now. Try again later.
Articles 1–20